STOCK TITAN

scPharmaceuticals Inc. (SCPH) Net Income by Year

SCPH

scPharmaceuticals Inc. reported a net loss of $85.1M in fiscal year 2024. This represents a decrease of 55.4% from the prior fiscal year. Over the trailing 12 months, Q3 FY2024 through Q2 FY2025, the same line adds up to a $91.7M net loss. The table below carries 9 fiscal years, from 2016 to 2024, and the quarters scPharmaceuticals Inc. has filed alongside them.

FY2024 annual
Net Income -$85.1M
YoY -55.4%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2025, ended Jun 30, 2025 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

SCPH Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-K
Net Income-$91.7M-$85.1M-55.4%-$54.8M-48.8%-$36.8M-31.4%-$28.0M+13.0%-$32.2M+2.4%-$33.0M-12.1%-$29.4M-23.6%-$23.8M+2.3%-$24.4M

TTM is the trailing twelve months, Q3 FY2024 through Q2 FY2025, summed from the four most recent quarterly filings.

SCPH Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2510-QQ1'2510-QQ4'2410-QQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-QQ2'2310-QQ1'2310-QQ4'2210-KQ3'2210-Q
Net Income-$18.0M-5.5%-$19.7M-39.9%-$18.8M-36.4%-$35.1M-124.5%-$17.1M-20.7%-$14.1M-25.9%-$13.8M-$15.6M-53.8%-$14.2M-46.0%-$11.2M-45.0%N/A-$10.2M-55.1%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More scPharmaceuticals Inc. financials

Frequently Asked Questions

What was scPharmaceuticals Inc.'s net income in fiscal year 2024?

scPharmaceuticals Inc. reported a net loss of $85.1M in fiscal year 2024.

How fast is scPharmaceuticals Inc.'s net income growing?

scPharmaceuticals Inc. (SCPH) net income fell by 55.4% year over year, from -$54.8M to -$85.1M in fiscal year 2024.

What is scPharmaceuticals Inc.'s net income over the last twelve months?

scPharmaceuticals Inc. (SCPH) reported a $91.7M net loss over the trailing 12 months, Q3 FY2024 through Q2 FY2025, summed from the four most recent quarterly filings.

Across the 9 fiscal years this page covers, scPharmaceuticals Inc. (SCPH) net income went from -$24.4M in fiscal year 2016 to -$85.1M in fiscal year 2024.

scPharmaceuticals Inc. (SCPH) reported -$18.0M in net income in Q2 2025. This represents a decrease of 5.5% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what scPharmaceuticals Inc. (SCPH) reported on that line in every period on record.